Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Fennec Pharmaceuticals Inc T.FRX

Alternate Symbol(s):  FENC

Healthcare Biotechnology
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was... see more

Current News (TSX:FRX)

Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss

GlobeNewswire 5 days ago

Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire 11 days ago

Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption

GlobeNewswire November 19, 2025

Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada

GlobeNewswire November 18, 2025

Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

GlobeNewswire November 17, 2025

Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada

GlobeNewswire November 13, 2025

Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares

GlobeNewswire November 13, 2025

Fennec Pharmaceuticals Announces Proposed Offering of Common Shares

GlobeNewswire November 13, 2025

Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire November 13, 2025
View More News ››

Opinion & Analysis (TSX:FRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:FRX)

Fennec Pharmaceuticals Inc. (FENC): Capitalizing on the Unme

Looks like FENC is making serious moves in the pediatric cancer space. $22M in net product sales for 9 months is impressive, especially...
MikeTester - January 24, 2025

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter

~ Achieved PEDMARK® Full-Year 2023 Net Product Sales of $21.3 Million, Including $9.7 Million in Net Product Sales in the...
Betteryear2 - March 21, 2024

Norgine exclusive agreement

for Europe.  Should be a good day for Fennec !!! Still waiting on that buyout
willyk3 - March 17, 2024

RE:Pedmark approved

Pedmark commercially available as of today!!! Great news for everyone involved..investors and patients alike.
willyk3 - October 17, 2022

Pedmark approved

by the US FDA.    Finally!!!! Now ....about that takeout??
willyk3 - September 21, 2022

Fennec Pharmaceuticals Up to $45 M Investment From Petrichor

~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to be Funded Upon Potential...
Betteryear2 - August 1, 2022
View more Bullboard ››

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd., together with its subsidiaries, engages in the exploration, development, and production of oil and gas in ...
View More »